Matthew Kilmurry, M.D. St. Mary’s General Hospital Grand River Hospital.

Slides:



Advertisements
Similar presentations
Follow-up of GI Cancers Dr. Marianne Taylor BC Cancer Agency – CSI November 29, 2003.
Advertisements

Treatment.
A Slide Presentation for Oncology Nurses
These are actual cases to –Stimulate your reading –Test your knowledge of the material Look for the sound icon (often in the upper right hand corner.
Lung Cancer for Finals SypRFSignsCompInxHistologyRxSurg Simple Success Tim Robbins Academic FY1 UHCW.
CORE Case 2 Workshop Petra Lewis MD Professor of Radiology and OBGYN
By Dr Varuna Paranahewa
Carcinoid tumors. Develop from the argyrophillic Kulchitsky’s cells that are present in the airway mucosa Neuroendocrine tumor categorized Grade I : typical.
Metastatic involvement (M) M0 - No metastases M1 - Metastases present.
62 years old man Main complaint: Back pain at night but not during the day Loss of appettite Weight loss.
Primary Pulmonary Sarcoma
Management of Solitary Pulmonary Nodule Marvin D. Peyton, M.D. Thoracic and Cardiovascular Surgery University of Oklahoma Health Sciences Center.
DEVELOPMENT AND IMPLEMENTATION OF A LUNG NODULE PROGRAM Tamra Kelly, BS RRT-NPS, Gary B. Mertens, RCP, CPFT, Jenifer Beasley, RRT, Departments of Cancer.
Screening for Lung Cancer Jess Dalehite, M.D. Southwest Medical Imaging Midland Memorial Hospital.
PLWC Slide Deck Series: Understanding Lung Cancer Presents 2006.
Breast Cancer 101 Barbara Lee Bass, MD, FACS Professor of Surgery
Lung Cancer Overview MaXiaoBiao Yun nan biotherapy center.
Lung malignancy Dr Rachel Cary, FY1 Warwick Hospital.
 ,463 people  ,371 deaths  9/10 lung cancer >60 years  Only 5% adult lung cancer predicted to survive ≥10 years.
John Doyle, Jon Hood, Jimmy Svab. Lung Cancer is the uncontrolled growth of abnormal cells. Abnormal cells do not develop into healthy tissue. Instead.
By Rachel, Xiao Xia, Helen. Introduction Definition Symptoms Causes Prevention Treatment Prognosis Statistics Conclusion.
1 By Dr. Zahoor. 2 1 Answer 1 Right middle lobe pneumonia (abnormal whiteness in the right lung) 3.
AJCC Staging Moments AJCC TNM Staging 7th Edition Lung Case #3 Contributors: Valerie W. Rusch, MD Memorial Sloan-Kettering Cancer Center, New York, New.
Mesothelioma. Is a malignant tumour of pleura, usually resulting from asbestos exposure. Asbestos is the major single cause and there is a history of.
Lung Cancer Morbidity in Baltimore City & Chicago By Calandra Dyson Lyliane Mbah MoniQue Veney Promise Okafor.
TYPES, CAUSES, SYMPTOMS, TREATMENTS, STATISTICS, & PICTURES HEATHER XXXXXXX, 1 ST PERIOD Lung Cancer 1
AJCC Staging Moments AJCC TNM Staging 7th Edition Lung Case #1 Contributors: Valerie W. Rusch, MD Memorial Sloan-Kettering Cancer Center, New York, New.
SURGEONS ROLE AND INVOLVEMENT IN SBRT PROGRAM Stephen R. Hazelrigg, M.D. Professor and Chair, Cardiothoracic Surgery Southern Illinois University, School.
© Copyright 2003 Cardinal Health, Inc. or one of its subsidiaries. All rights reserved. PET in Colorectal Cancer Early detection of disease Precise Staging.
NECN Lung NSSG April 2012 Managing Solitary Brain Metastases from NSCLC Dr Paula Mulvenna Consultant Clinical Oncologist Northern Centre for Cancer Care.
Dr A.J.France, Ninewells Hospital, Dundee Lung cancer treatment 2010 © A.J.France 2010.
Thorax / Lung Basic Science Conference 12/21/2005 J.R. Nitzkorski.
Thoracic Surgery By Mike Poullis.
SURGERY FOR NSCLC GREG CHRISTODOULIDES MD, FACS, FCCP, FESTS
SYB Case 2 By: Amy. History 63 y/o female History of left breast infiltrating duct carcinoma s/p mastectomy in 1996 and chemotherapy ER negative, PR negative,
Dr A.J.France. Ninewells Hospital, Dundee Lung Cancer 2010.
PRESENTING LUNG CANCER. Lung Cancer: Defined  Uncontrolled growth of malignant cells in one or both lungs and tracheo-bronchial tree  A result of repeated.
Resection For Lung Metastases M62 Coloproctology Course.
Chapter 28 Lung Cancer. Mosby items and derived items © 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 2 Objectives  Describe the epidemiology of.
#1008 New Strategies in Treatment of Lung Cancer November 9 to 12 Patrick Ross, Jr. MD, PhD Assistant Professor of Surgery Division of Surgical Thoracic.
Lung Cancer in 2011 Dr. Natasha Leighl, MD MMSc FRCPC Medical Oncologist, Princess Margaret Hospital Assistant Professor, Medicine, University of Toronto.
WHAT ARE THE RISK FACTORS FOR LUNG CANCER? SMOKING.
Malignant Pleural Effusion (M.P.E.)
THORACIC CLUB MEETING AHMADU BELLO UNIVERSITY TEACHING HOSPITAL,ZARIA,NIGERIA PLEURAL TUMORS.
LUNG CANCER DR HUDA BADRI. OVERVIEW OF SESSION Learning objectives Quiz Tutorial on lung cancer and guidelines 15 minutes break Case studies 10minutes.
Cancer Education Day May 13, Surgery for Lung Cancer Dr A Elalem Thoracic surgeon Windsor Regional hospital.
Pulmonary Medicine Department Ain Shams University
Cancer Education Day Diagnostic Assessment Programs DAPs May 13, 2016.
Lung cancer Gene Kukuy, MD Cardiothoracic Surgery.
 Lung Cancer Sydney Freedman and Rachel Rea. Causes  No exact cause  Smokers and non-smokers can get lung cancer  Smoke causes cancer by damaging.
Implementation of a lung health clinic in high-risk individuals in South East London: a prospective feasibility cohort study Background In 2013, lung cancer.
Instructor Kathleen Gamblin, RN, BSN, OCN Oncology Nurse Navigator
Multi-station N2 Ca Lung
Brain imaging prior to lung cancer resection
CASE 1: Management of metastatic disease in a resource-limited setting
Challenges of Rare Cancers…
The Uganda Cancer Institute Experience Walusansa Victoria.
Bronchial Carcinoma Part 2
QUESTIONS OF LUNG CANCER
LUNG CARCINOMA (BRONCHIAL CARCINOMA)
2epart EXTRAPULMONARY SMALL CELL CANCER OF THE ESOPHAGUS INTRODUCTION
Lung Cancer Screening:
Lung Cancer Screening Sandra Starnes, MD Professor of Surgery
Surgical Treatment of Metachronous Second Primary Lung Cancer
The Nuances of Staging Lung cancer Gerard A
Pulmonary nodules discovered on CT scan of the chest
Can FDG-PET reduce the need for mediastinoscopy in potentially resectable nonsmall cell lung cancer?  Kemp H Kernstine, MD, PhD, Kelley A McLaughlin,
General strategies of Cancer Treatment and evaluation of Response
NSCLC: Staging and TNM classification
Presentation transcript:

Matthew Kilmurry, M.D. St. Mary’s General Hospital Grand River Hospital

I have no conflicts of interest

The problem  2003 numbers for Ontario 7500 new cases 6300 deaths  Only 25% of cases are surgically resectable  Breast cancer in 2007 was 8000 new cases and 2000 deaths

Causes  Smoking  Radon exposure  Asbestos exposure  Second hand smoke  Genetics

Types of Lung Cancer  Primary  Secondary Colonic mets Other primaries

Resection of pulmonary mets  Several prognostic factors Disease free interval Number of mets Resectability  30% long term survival  Do not assume it is a met Old study suggests 73% of pulmonary nodules in patients with previous cancer will be new primary

Primary lung cancer  Small cell  Non small cell Accounts for % of primary lung tumors

Screening  No accepted screening method Studies using CT, CXR and sputum  High index of suspicion smokers

Staging  Stage I: no lymph node involvement  Stage II: lymph nodes involved or tumor invading into chest wall  Stage III: mediastinal nodal involvement or bad tumour factors  Stage IV: metastatic disease

Nodal stations

Surgical Approach  Diagnosis: Is this cancer?  Metastases: Is there spread?  Suitability: Is the patient healthy enough for surgery?

Diagnosis  History and physical  Chest X-ray  CT scan  Percutaneous biopsy  Bronchoscopy

Metastases  History and physical  Upper abdominal imaging  Bone scan and CT head  PET scan  Mediastinoscopy

Nodal stations

Suitability  History and physical  PFT’s  Cardiac investigations 2D echo Stress test Nuclear medicine  CPET  Quantitative V/Q scan

Treatment  Stage I and II are generally offered surgery with stage II getting post op chemo  Some stage III can be offered surgery – usually after chemoradiotherapy  Rare stage IV patients can be offered surgery Solitary brain mets

Treatment  Lobectomy preferred approach Limited resection has higher recurrence and worse long term suvival  Stage survival, 5 years Stage I – 60-70% Stage II – 40-50% Stage III – 15-25% Stage IV – 0-10%

Case # 1  65 year old male previous smoking history  Chest X-ray done as part of annual health exam  CT confirmed mass in LUL Small lesion also noted in RUL

Case # 1

 Bronchoscopy and mediastinoscopy showed no evidence of mets  Thoracotomy confirmed diagnosis and had lobectomy  Right upper lobe nodule unchanged over two years

Case # 2  68 year old woman had pneumonia like symptoms which led to chest X-ray  Smoker of 1 pack per day for 45 years

Case # 2

 CT chest showed large tumour with no evidence of mets  Biopsy shows NSCLC  PET scan shows no evidence of metastatic disease

Case # 2  Mediastinoscopy showed metastatic disease in lymph nodes  Referred for chemoradiotherapy  Possible candidate for surgery

Palliation  Majority of work with chemo and radiotherapy  Pain and symptom management vital  Surgery sometimes required Pleural effusions Endobronchial tumours

Thoracic DAU  Run through Grand River Cancer Center  Multidisciplinary clinic with respirologists and thoracic surgeons  Referrals accepted through GRCC Main criteria is newly abnormal chest X-ray

Thoracic Program  Combined thoracic surgery at St. Mary’s General Hospital  CCO pushing to eliminate low volume thoracic centers  Working to keep thoracic surgery in Kitchener-Waterloo

Conclusions  Lung cancer is a major health concern in Ontario  Surgery offers best chance for cure in resectable cases  Multidisciplinary care required and available in our region